UFP Technologies, Inc.

UFPT Healthcare Medical Devices

UFP Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $602.8 million, up 19.5% from fiscal 2024.

Revenue
+11.6%
EPS
+25.6%
Free cash flow
−35.8%
Total debt
−40.2%

Quarter to September 2026, against a year earlier

301.02 1.20 +0.40%
Market cap
$2.3B
P/E
30.1×
Fwd P/E
29.2×
Dividend yield
—
F-score
5/9
Altman Z
6.86
Beneish M
−2.57
Dividend safety
n/a

UFP Technologies, Inc. (UFPT) P/B ratio

Alert me on P/B ratio

As of 5 November 2026, UFP Technologies, Inc. (UFPT) trades at a P/B ratio of 5.0×. Over the past ten years it has ranged from 1.4× (July 2015) to 8.9× (September 2024); the current reading is higher than 87% of that period. That is above the Medical Devices industry median of 2.5× and above the Healthcare sector median of 2.3×.

P/B ratio, daily

Embed this chart

Annual newest first

Period P/B ratio Change
FY2025 4.0× (26.22%)
FY2024 5.5× 23.76%
FY2023 4.4× 20.09%
FY2022 3.7× 35.37%
FY2021 2.7× 37.89%
FY2020 2.0× (13.28%)
FY2019 2.3× 44.70%
FY2018 1.6× (2.65%)
FY2017 1.6× (1.44%)
FY2016 1.6× 0.26%

Quarterly newest first

Period P/B ratio Change
Sep 2026 5.0× 12.04%
Jun 2026 4.4× 30.29%
Mar 2026 3.4× (15.61%)
Dec 2025 4.0× 5.90%
43 more quarters

Against its own ten years

Low 1.4× High 8.9×
Ten-year median 2.1×
Current reading's percentile 86

P/B ratio against peers

What P/B ratio is

Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.

Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))

The full definition of P/B ratio →

More on UFPT